E2F1/ATF4,ZFP36线,E2F1/ATF4

Shiyue Qin1, Hongyang Kong2, Lei Jiang2

  • 1Department of Ophthalmology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou School of Clinical Medicine, Nanjing Medical University, Taizhou, Jiangsu, 225300, China.

概括

指蛋白36 (ZFP36) 通过促进铁和线粒体功能障碍来抑制骨髓瘤 (OS) 的进展. ZFP36针对E2F1/ATF4通路,为OS治疗提供了一个潜在的治疗策略.